Patents by Inventor Thomas LANGMANN

Thomas LANGMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polysialic acid and use for treatment of neurodegenerative and neuroinflammatory diseases
    Patent number: 9944721
    Abstract: The present invention relates to a branched or unbranched free or glycosidically bound polysialic acid according to general formula (1) as given as follows poly-(?(2?8 or 2?9)Neu5Ac)n (1) wherein Neu5Ac is N-acetylneuraminic acid, and n is an integer in the range from 14 to 26 and/or pharmaceutically acceptable salts thereof, a polysaccharide composition comprising the polysialic acid (1), and the use as a medicament, particularly in the therapeutic and/or prophylactic treatment of degenerative, demyelinating and inflammatory diseases of the central nervous system, and degenerative or inflammatory retinal diseases.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: April 17, 2018
    Assignees: RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONN, UNIVERSITÄT ZU KÖLN
    Inventors: Harald Neumann, Jens Kopatz, Anahita Shahraz, Marcus Karlstetter, Thomas Langmann
  • Polysialic acid and use for treatment of neurodegenerative and neuroinflammatory diseases
    Publication number: 20160046734
    Abstract: The present invention relates to a branched or unbranched free or glycosidically bound polysialic acid according to general formula (1) as given as follows poly-(?(2?8 or 2?9)Neu5Ac)n (1) wherein Neu5Ac is N-acetylneuraminic acid, and n is an integer in the range from 14 to 26 and/or pharmaceutically acceptable salts thereof, a polysaccharide composition comprising the polysialic acid (1), and the use as a medicament, particularly in the therapeutic and/or prophylactic treatment of degenerative, demyelinating and inflammatory diseases of the central nervous system, and degenerative or inflammatory retinal diseases.
    Type: Application
    Filed: March 18, 2014
    Publication date: February 18, 2016
    Inventors: Harald NEUMANN, Jens KOPATZ, Anahita Shahraz, Marcus KARLSTETTER, Thomas LANGMANN